The House Dec. 11 voted 320-71 to pass legislation (H.R. 5378) that would delay a Jan. 19 payment reduction to Medicaid disproportionate share hospitals for two years, but permanently reduce Medicare payments for drug administration services in off-campus hospital outpatient departments. Among other provisions, the bill codifies the Hospital Price Transparency Rule but makes key changes, including no longer allowing the use of price estimator tools to meet the shoppable services requirement and increasing civil monetary penalties for noncompliance.

“While the AHA appreciates inclusion of a two-year delay on DSH cuts, we have been very clear regarding the harm that would be done to our nation’s hospitals if so-called site-neutral cuts to Medicare were adopted,” AHA President and CEO Rick Pollack said in a statement shared yesterday with reporters and House members. 

Related News Articles

Headline
A KFF brief released yesterday compares the potential $880 billion in federal Medicaid cuts from the House-passed budget resolution to states' tax…
Headline
A JAMA Network Open study published March 13 found that 90% of Medicaid managed care plans cover at least one alcohol use disorder medication without prior…
Headline
The Medicaid and CHIP Payment and Access Commission released its March 2025 report to Congress March 13. The first chapter makes three recommendations on…
Headline
The Senate Finance Committee March 14 held a confirmation hearing on Mehmet Oz's nomination for administrator of the Centers for Medicare & Medicaid…
Headline
The Centers for Medicare & Medicaid Services March 12 announced that it will end four payment models early, terminating each by the end of 2025. The models…
Headline
The AHA March 11 shared ways Congress could better support patient access to post-acute care in comments for a hearing held by the House Committee on Ways and…